Ignite Creation Date:
2025-12-24 @ 11:45 PM
Ignite Modification Date:
2026-02-20 @ 11:31 AM
Study NCT ID:
NCT04572451
Status:
RECRUITING
Last Update Posted:
2025-08-01
First Post:
2020-09-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma
Sponsor:
Yana Najjar
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Melanoma | View |
| None | Unresectable Solid Tumors | View |
| None | Neoplasms | View |
| None | Neoplasms by Histologic Type | View |
| None | Neoplasms by Site | View |
| None | Antineoplastic Agents, Immunological | View |
| None | Antineoplastic Agents | View |
| None | Immune Checkpoint Inhibitors | View |
| None | Molecular Mechanisms of Pharmacological Action | View |
| None | Nivolumab | View |